Delivery Order SPE2DB22D2218-SPE2DB25FR3EZ
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,449,252 units of the pharmaceutical drug Oseltamivir Phosphate 75 mg capsules. The $1,022.92 order has a completion date of January 26, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as a prime contractor providing a range of pharmaceutical products and medical supplies to the Department of...
- This is a delivery order award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,109.24 firm fixed-price contract is for the delivery of Oseltamivir Phosphate 75 mg capsules, which are used to treat influenza. The award is under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of Oseltamivir Phosphate 75 mg capsules. The contract has a total ceiling value of $2,129.64 and is a firm fixed-price delivery order with a completion date of January 17, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Oseltamivir Phosphate 75 mg capsules in unit doses of 10s, with a ceiling value of $2,657.60. The contract is a Firm Fixed Price Delivery Order, with a performance period ending on July 9, 2025. The contract is not set-aside and was awarded on July 8, 2025. AmerisourceBergen Drug Corp...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, to provide 4,563,795,316 units of the drug Oseltamivir Phosphate 75 mg capsules. The $1,317.58 order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded to Amerisourcebergen Drug Corp by DLA to deliver a comprehensive range of pharmaceutical products and...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,853.16 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide Oseltamivir Phosphate 75 mg capsules. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical, which covers a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,563,283,081 units of the antiviral drug Oseltamivir Phosphate 75 mg capsules. The firm-fixed-price delivery order, valued at $1,382.20, has a completion date of January 10, 2024 and does not utilize any set-aside requirements. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the procurement of Oseltamivir Phosphate 75 mg capsules. The contract has a ceiling value of $6,534.13 and runs through March 19, 2025. It is a firm-fixed price contract with no set-aside designation, indicating open competition. AmerisourceBergen has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,861.68 firm fixed-price contract covers the supply of Oseltamivir Phosphate 75 mg capsules. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical...
- This is a delivery order (SPE2DB25FT8Q1) awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,013,668 units of the medication Oseltamivir Phosphate 75 mg capsules, with a ceiling value of $1,248.60. The award has an ultimate completion date of January 23, 2025 and is a firm fixed-price contract with no set-aside designation, indicating open competition....
- SPE2DB22D2218Indefinite Delivery Contract
- SPE2DB22D2218-SPE2DB25FR3EZDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Oseltamivir Phosphate 45 mg capsules in unit dose packaging of 10 units. This contract represents a firm fixed price delivery order with a ceiling value of $4,604.97 and an ultimate completion date of August 20, 2025. The award was competitively procured with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to military healthcare systems worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, leverages its extensive capabilities across multiple therapeutic domains to fulfill military and veteran healthcare requirements. The company's federal contract portfolio demonstrates consistent success in competitively awarded transactions with the Defense Logistics Agency, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies. This Oseltamivir delivery order reflects the company's ongoing role in supporting Defense Health Agency and broader military healthcare operations through flexible and comprehensive contract vehicles designed to meet diverse pharmaceutical supply needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.6k | 8/19/25 |